Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc.
ESPR
Valuace
100
Růst
83
Zdraví
63
Cena
$ 2.79
Dnes
--0.09 (-2.88%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.6B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
1B
ROE
23%
ROA
-29%
PE
-32
PS
2
Cena 1R
1-4
⌀ Cena
2.15
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
03-03-2026
Poslední dividenda

Profil

Esperion Therapeutics, Inc., farmaceutická společnost, vyvíjí a komercializuje léčivé přípravky pro léčbu pacientů se zvýšenou nízkou hustotou lipoproteinového cholesterolu. Jeho hlavními kandidáty jsou tablety NEXLETOL (kyselina bempedová) a NEXLIZET (kyselina bempedová a ezetimib) pro léčbu pacientů s aterosklerotickým kardiovaskulárním onemocněním nebo heterozygotní familiární hypercholesterolemií. Společnost uzavřela licenční smlouvu a smlouvu o spolupráci se společností Daiichi Sankyo Europe GmbH; a Serometrix, aby získala licenci na svůj program inhibitorů PCSK9 pro ústní a malé molekuly. Společnost Esperion Therapeutics, Inc. byla založena v roce 2008 a sídlí v Ann Arbor v Michiganu.
Sektor
Healthcare
Odvětví
Drug Manufacturers - Specialty & Generic
Počet zaměstnanců
304
Založení
2013-06-26
Adresa
3891 Ranchero Drive
CEO
Sheldon L. Koenig

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 202520242023202220212020201920182017201620152014201320122011
Total Revenues403.1403.1332.3116.375.578.4227.5148.4184.50.00.00.00.04,977.00.00.0
Cost of Revenues143.4129.268.643.327.014.22.40.00.00.00.00.00.00.00.00.0
Gross Profit259.8273.9263.773.148.564.2225.2148.4184.50.00.00.00.04,977.00.00.0
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues168.487.382.465.069.151.673.8137.732.334.0
Cost of Revenues27.955.428.531.525.617.315.610.111.513.4
Gross Profit140.631.953.833.543.534.358.2127.720.820.6
Operating Income TTM 202520242023202220212020201920182017201620152014201320122011
R&D Expenses0.00.00.086.1118.9106.0146.9175.6171.5147.657.929.825.316.08.07.8
Selling General & Admin Expenses0.00.00.0142.5109.1185.0199.665.933.121.418.320.210.96.72.22.4
Depreciation & Amortization0.10.10.10.22.74.00.54.10.30.30.30.20.20.10.10.2
Total Operating Expenses199.5213.6209.3228.6228.0291.0346.6241.5204.6169.076.250.036.222.810.210.2
Operating Income60.360.354.4-155.6-179.5-226.7-121.4-93.1-204.6-169.0-76.2-50.0-36.2-22.8-10.2-10.2
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.017.714.9
Selling General & Admin Expenses0.00.00.00.00.00.00.00.045.433.2
Depreciation & Amortization0.00.00.00.00.00.00.00.00.00.0
Total Operating Expenses55.441.846.755.647.950.455.655.463.261.5
Operating Income85.2-10.07.1-22.1-4.4-16.02.672.3-42.4-27.5
Net Income TTM 202520242023202220212020201920182017201620152014201320122011
Interest Income1.13.50.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Interest Expense84.684.659.359.056.846.422.78.10.10.20.40.50.30.91.50.6
Other Expense-81.1-81.1-106.1-53.7-54.2-42.4-22.2-4.12.82.21.50.80.1-2.4-0.1-0.1
IBT-20.8-20.8-51.7-209.2-233.7-269.1-143.6-97.2-201.8-167.0-75.0-49.8-36.4-26.1-11.7-10.8
Income Tax Expense1.81.80.00.054.249.722.611.92.92.11.71.10.21.11.40.5
Net Income-22.7-22.7-51.7-209.2-287.8-318.8-166.2-109.0-201.8-167.0-75.0-49.8-36.4-26.1-11.7-10.8
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income1.10.00.00.00.00.00.00.00.91.3
Interest Expense22.622.120.519.416.415.113.714.015.115.0
Other Expense-21.6-21.4-19.8-18.4-16.9-13.5-64.5-11.2-14.0-13.7
IBT63.7-31.3-12.7-40.5-21.3-29.5-61.961.0-56.3-41.3
Income Tax Expense1.80.00.00.00.00.00.00.0-27.40.0
Net Income61.8-31.3-12.7-40.5-21.3-29.5-61.961.0-56.3-41.3
Per Share Data TTM 202520242023202220212020201920182017201620152014201320122011
EPS$0.00$0.00$0.00$-2.03$-4.33$-11.03$-6.05$-4.02$-7.54$-6.98$-3.33$-2.26$-2.22$-3.31$-16.25$-14.97
EPS Diluted$0.00$0.00$0.00$-2.03$-4.33$-11.03$-6.05$-4.02$-7.54$-6.98$-3.33$-2.26$-2.22$-3.31$-16.25$-14.97
Shares Outstanding236.7207.9187.2103.166.428.927.527.126.823.922.522.016.47.90.70.7
Diluted Shares Outstanding284.6207.9187.2103.166.428.927.527.126.823.922.522.016.47.90.70.7
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.50$-0.37
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.50$-0.37
Shares Outstanding236.7198.2196.8196.1195.6194.9188.8169.3112.4111.9
Diluted Shares Outstanding284.6198.2196.8196.1195.6194.9188.8189.6112.4111.9
Current Assets TTM 20242023202220212020201920182017201620152014201320122011
Cash And Equivalents189.3144.882.2124.8208.9305.0166.137.034.538.277.385.056.56.51.6
Short Term Investments0.00.00.042.150.40.034.799.1165.7173.4134.920.83.50.00.0
Total Cash & ST Investments189.3144.882.2124.8208.9305.0166.137.034.538.277.385.060.16.51.6
Accounts Receivable60.480.148.533.722.90.00.00.00.00.00.00.00.00.00.0
Inventory84.594.565.635.234.416.10.00.00.00.00.00.00.00.00.0
Other Current Assets11.018.64.79.962.824.810.96.63.72.02.10.90.60.60.3
Total Current Assets345.1338.0201.1246.7329.0345.9211.7142.6203.9213.6214.4106.860.67.11.9
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents92.486.1114.6144.8144.7189.3226.682.2114.8138.5
Short Term Investments0.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments92.486.1114.6144.8144.7189.3226.682.2114.8138.5
Accounts Receivable119.0107.781.380.167.860.454.648.542.640.8
Inventory141.8114.599.394.580.184.573.165.651.445.7
Other Current Assets7.234.323.518.614.911.011.34.79.37.2
Total Current Assets360.5342.6318.8338.0307.6345.1365.6201.1218.2232.1
Long-Term Assets TTM 20242023202220212020201920182017201620152014201320122011
Net Property, Plant & Equipment7.25.84.71.22.67.32.70.50.40.70.80.80.10.10.3
Goodwill0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.10.10.10.10.10.10.10.10.10.10.10.10.10.10.1
Long-Term Investments0.00.00.042.150.40.034.799.3239.2204.3215.256.517.50.00.0
Other Long-Term Assets0.00.00.0-42.150.00.0-34.7-99.1-165.7-173.4-134.9-20.80.00.00.0
Total Long-Term Assets7.25.84.71.352.67.42.70.873.931.681.236.617.70.20.3
Total Assets352.3343.8205.8247.9381.6353.3214.4143.5277.8245.2295.6143.378.37.32.2
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment3.54.45.25.86.57.27.44.73.02.4
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.10.10.10.10.10.10.10.10.10.1
Long-Term Investments0.00.00.00.00.00.00.00.00.00.0
Other Long-Term Assets0.00.00.00.00.00.00.00.00.0-2.5
Total Long-Term Assets3.64.55.35.86.67.27.54.73.12.5
Total Assets364.0347.1324.0343.8314.1352.3373.1205.8221.3234.6
Current Liabilities TTM 20242023202220212020201920182017201620152014201320122011
Accounts Payable47.751.731.723.017.652.028.944.920.44.60.72.02.20.50.7
Short-Term Debt35.4104.936.40.41.42.60.50.01.01.71.60.60.015.20.0
Other Current Liabilities71.681.262.765.448.737.834.619.411.79.23.32.72.00.30.6
Current Liabilities175.3246.2156.292.373.494.166.164.333.115.65.65.54.217.21.3
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable77.574.772.051.734.947.728.431.726.224.6
Short-Term Debt152.1123.857.557.32.72.746.036.437.923.5
Other Current Liabilities129.4100.3136.9128.7113.2104.360.762.753.843.5
Current Liabilities359.0298.8271.0246.2165.9175.3164.5156.2137.7107.2
Long-Term Liabilities TTM 20242023202220212020201920182017201620152014201320122011
Long-Term Debt517.2486.3504.6260.6258.8182.81.10.00.01.02.74.30.07.56.9
Capital Leases4.05.34.61.01.96.01.60.00.00.00.00.00.00.00.0
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Total Liabilities696.5732.5660.8571.7578.5449.4194.564.333.116.68.39.84.224.78.2
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt448.9474.4240.3240.3266.2266.5502.8504.6263.2262.4
Capital Leases3.24.14.85.36.04.04.43.03.02.4
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities815.4780.6750.2732.5684.3696.5667.4660.8631.3606.6
Total Common Equity TTM 20242023202220212020201920182017201620152014201320122011
Common Stock0.20.20.10.10.10.00.00.00.00.00.00.00.00.00.0
Retained Earnings-1,550.2-1,601.0-1,549.3-1,340.0-1,106.4-838.8-695.3-598.1-396.3-229.2-154.2-104.4-68.1-42.0-30.2
Comprehensive Income0.00.00.00.00.00.00.0-0.3-0.8-0.2-0.5-0.10.0-1.2-1.0
Total Common Equity-344.2-388.7-455.0-1,340.0-1,106.4-838.8-695.3-598.1244.7228.6287.3133.674.1-17.4-6.1
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.20.20.20.20.20.20.20.10.10.1
Retained Earnings-1,685.5-1,654.2-1,641.5-1,601.0-1,579.7-1,550.2-1,488.3-1,549.3-1,492.9-1,451.7
Comprehensive Income0.00.00.00.00.00.00.00.00.00.0
Total Common Equity-451.4-433.5-426.2-388.7-370.2-344.2-294.3-455.0-410.0-372.0
Other TTM 20242023202220212020201920182017201620152014201320122011
Total Debt556.6591.2540.9260.9260.2185.41.60.01.02.74.34.90.022.86.9
Book Value-344.2-388.7-455.0-323.8-196.9-96.120.079.1244.7228.6287.3133.674.1-17.4-6.1
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value-451.4-433.5-426.2-388.7-370.2-344.2-294.3-455.0-410.0-372.0
Cash Flow From Operating Activities TTM 202520242023202220212020201920182017201620152014201320122011
Net Income-86.5-22.7-51.7-209.2-233.7-269.1-143.6-97.2-201.8-167.0-75.0-49.8-36.4-26.1-11.7-10.8
Depreciation & Amortization0.50.10.10.20.50.60.50.30.30.30.30.20.20.10.10.2
Stock-Based Compensation12.39.912.012.015.224.328.425.924.018.616.012.73.71.20.10.1
Change Working Capital-1.1-14.6-60.513.7-3.4-52.5-4.3-7.329.216.510.0-2.10.33.2-0.80.8
Change In Accounts Receivable-18.2-60.0-31.6-14.8-10.8-10.5-10.70.00.00.00.00.00.00.00.00.0
Change In Accounts Payable11.220.912.48.75.6-34.123.1-16.124.415.83.9-1.3-0.31.8-0.20.6
Change In Inventories-33.7-10.6-28.9-30.4-0.8-18.3-16.10.00.00.00.00.00.00.00.00.0
Other Non-cash Items85.814.376.648.046.535.533.88.1-0.20.00.00.10.00.91.50.6
Cash from Operations-27.30.00.0-135.5-174.8-263.8-85.2-70.3-148.6-131.3-47.7-38.2-32.0-18.1-10.8-9.1
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income61.8-31.3-12.7-40.5-21.3-29.5-61.961.0-56.3-41.3
Depreciation & Amortization1.40.90.00.70.0-0.40.00.00.00.0
Stock-Based Compensation2.42.32.72.52.83.00.00.02.93.0
Change Working Capital-21.39.7-26.312.0-21.3-12.4-5.0-21.84.06.6
Change In Accounts Receivable-21.2-11.2-26.5-1.2-12.3-7.5-5.7-6.1-5.9-1.8
Change In Accounts Payable-12.40.02.627.89.3-12.819.3-3.55.51.7
Change In Inventories3.45.9-15.1-4.8-14.44.4-11.4-7.5-14.2-5.8
Other Non-cash Items0.914.14.92.64.84.059.714.629.912.3
Cash from Operations0.00.00.00.00.00.00.00.0-37.1-19.3
Cash Flow From Investing Activities TTM 202520242023202220212020201920182017201620152014201320122011
Capital Expenditure-0.10.2-0.30.00.00.0-13.4-1.0-0.20.0-0.1-0.3-0.90.00.00.0
Acquisitions0.00.00.00.00.00.012.50.00.00.00.00.00.00.00.00.0
Investments0.00.00.00.0-59.9-50.5-4.4-34.3-25.5-219.6-197.2-280.6-48.1-24.70.00.0
Sales of Investment17.50.00.042.568.00.039.199.5166.1183.7207.4120.812.43.50.00.5
Other Investing Activities-25.00.00.00.00.00.0-12.50.00.00.00.00.00.00.20.00.0
Cash from Investing17.40.00.042.58.1-50.521.464.2140.4-35.910.1-160.1-36.6-21.00.00.5
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure0.20.00.00.00.0-0.2-0.1-0.10.00.0
Acquisitions0.00.00.00.00.00.00.00.00.00.0
Investments0.00.00.00.00.00.00.00.00.00.0
Sales of Investment0.00.00.00.00.00.00.00.00.00.0
Other Investing Activities0.00.00.00.00.00.00.00.0-42.50.0
Cash from Investing0.00.00.00.00.00.00.00.00.00.0
Cash Flow From Financing Activities TTM 202520242023202220212020201920182017201620152014201320122011
Debt Repaid-18.20.00.00.00.0-0.80.00.0-1.0-1.7-1.6-0.60.00.00.00.0
Debt Issued305.7591.250.3280.00.875.5183.81.60.00.00.00.04.9-22.815.96.9
Issuance of Common Stock57.40.00.056.990.8218.70.00.00.0164.00.0190.091.772.20.00.0
Repurchase of Common Stock0.00.00.00.00.00.0-55.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities56.90.00.0-6.4-58.250.3256.7136.211.71.20.01.25.416.915.76.7
Cash from Financing91.60.00.050.532.6268.2201.7136.210.7163.5-1.6190.597.189.115.86.7
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued601.02.8300.40.228.6-0.2-279.77.9276.81.0
Issuance of Common Stock0.00.00.00.00.00.00.00.052.4-52.5
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.0-48.048.1
Cash from Financing0.00.00.00.00.00.00.00.04.5-4.3
Cash position TTM 202520242023202220212020201920182017201620152014201320122011
Net Change in Cash81.723.162.5-42.5-134.1-46.1137.9130.12.5-3.7-39.2-7.728.550.04.9-1.8
Closing Cash Balance226.6167.9144.882.2124.8258.9305.0167.137.034.538.277.385.056.56.51.6
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash75.46.4-28.6-30.10.0-44.6-37.3144.4-32.6-23.6
Closing Cash Balance167.992.486.1114.6144.8144.7189.3226.682.2114.8
Free Cash Flow TTM 202520242023202220212020201920182017201620152014201320122011
Free Cash Flow-27.4-12.9-24.0-135.5-174.8-263.8-98.5-71.3-148.8-131.3-47.8-38.5-32.9-18.1-10.8-9.1
Real Free Cash Flow-39.7-22.8-36.0-147.4-190.0-288.1-126.9-97.2-172.8-149.9-63.8-51.2-36.6-19.4-10.9-9.2
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow45.4-4.3-31.4-22.6-35.0-35.5-7.353.8-37.1-19.3
Real Free Cash Flow43.0-6.6-34.1-25.1-37.8-38.5-7.353.8-40.0-22.3
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-32-92356.8
P/S1.86.470.5
P/B-1.66.22015.4
P/FCF-31.9-10.57573.5
Market cap$0.6$3.9
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets165.1 %45.1 %0 %
Debt to Income-2649.6 %-78.2 %0 %
Debt to Free cash flow-2638.9 %-4039.5 %0 %
Interest expense percentage140.4 %-12.3 %26.2 %
Current ratio1 8.6 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE5 %-33.2 %0 %
ROA-6.2 %-57.5 %0 %
CapEx to Revenue0 %1.3 %6 %
RaD to Revenue0 %106.1 %0 %
ROEM1,326,102.0 293379.4

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin53.5 %40.8 %74.8 %
Operating margin-9.7 %-160 %35 %
Net margin-34.8 %-186.9 %34.1 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding198.2 mil 49.8 mil
Employee count0.3 tis 0.2 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader